TCTR20190730001尚未招募未知
Alpha-tocopherol to reduced colistin nephrotoxicity in hospitalized patient
VitaminE0 个研究点目标入组 40 人开始时间: 2019年7月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Age over 18 year
- •Inpatients BAH receive colistin
排除标准
- •Bleeding tendency
研究者
相似试验
Unknown
3 期
Efficacy of Ascorbic Acid for Prevention of Colistin-Associated NephrotoxicityDrug SafetyNCT01501968Mahidol University54
招募中
3 期
The Effect of Curcumin Against Colistin-induced NephrotoxicityDrug-Induced NephropathyAcute Kidney InjuryNCT05613361October 6 University214
招募中
不适用
Evaluation of two alpha-tocopherol capsules effect on maternal and child vitamin E levelsVitamin E deficiencyC18.654.521.500.133.841RBR-9wch5mniversidade Federal do Rio Grande do Norte (Centro Cordenador)
已完成
4 期
Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced NephropathyContrast Induced NephropathyKidney DiseasesAdverse EffectsRenal FailureNCT00492518Technical University of Munich254
Unknown
3 期
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) PatientsContrast Induced NephropathyNCT01061320Thammasat University200